Scarborough Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Sell
937
-48
-5% -$11.2K 0.03% 136
2026
Q1
$241K Buy
+985
New +$229K 0.03% 130
2024
Q4
Sell
-1,477
Closed -$239K 115
2024
Q3
$239K Buy
+1,477
New +$235K 0.04% 80
2024
Q1
Sell
-1,444
Closed -$226K 562
2023
Q4
$226K Buy
1,444
+3
+0.2% +$460 0.05% 73
2023
Q3
$224K Buy
1,441
+215
+18% +$35.5K 0.05% 67
2023
Q2
$203K Buy
+1,226
New +$198K 0.05% 65

Other funds holding JNJ

Scarborough Advisors's JNJ Position: Q2 2026 in Review

Scarborough Advisors reduced its Johnson & Johnson (JNJ) stake by 4.9% in Q2 2026, selling an estimated $11.2K and leaving 937 shares worth $226K. The position accounts for 0.03% of the portfolio, ranked #136.

Scarborough Advisors first reported a position in JNJ in Q2 2023 and has held it in 6 quarters since. The position peaked at $241K in Q1 2026. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Scarborough Advisors held 937 shares of Johnson & Johnson worth $226K as of Q2 2026.
  • Scarborough Advisors sold 48 Johnson & Johnson shares in Q2 2026, an estimated $11.2K.
  • Johnson & Johnson made up 0.03% of Scarborough Advisors's portfolio in Q2 2026, its #136 holding.
  • Scarborough Advisors first reported a position in Johnson & Johnson in Q2 2023 and has held it in 6 quarters since.
  • Scarborough Advisors's Johnson & Johnson position peaked at $241K in Q1 2026.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.